We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 13, 2021

Minimal Residual Disease Detection Using a Plasma-Only ctDNA Assay in Patients With Colorectal Cancer

Clinical Cancer Research


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Cancer Research
Minimal Residual Disease Detection Using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients
Clin. Cancer Res 2021 Apr 29;[EPub Ahead of Print], AR Parikh, EE Van Seventer, G Siravegna, AV Hartwig, A Jaimovich, Y He, K Kanter, M Fish, KD Fosbenner, B Miao, S Phillips, JH Carmichael, N Sharma, J Jarnagin, I Baiev, YS Shah, IJ Fetter, HA Shahzade, JN Allen, LS Blaszkowsky, JW Clark, JS Dubois, JW Franses, B Giantonio, L Goyal, SJ Klempner, RD Nipp, EJ Roeland, DP Ryan, CD Weekes, JY Wo, TS Hong, L Bordeianou, CR Ferrone, M Qadan, H Kunitake, D Berger, R Ricciardi, JC Cusack, VM Raymond, A Talasaz, GM Boland, RB Corcoran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading